-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Adma Biologics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q2 2020 to Q4 2024.
- Adma Biologics, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $600K, unchanged year-over-year.
- Adma Biologics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $2.4M, unchanged year-over-year.
- Adma Biologics, Inc. annual Operating Lease, Payments for 2024 was $2.4M, unchanged from 2023.
- Adma Biologics, Inc. annual Operating Lease, Payments for 2023 was $2.4M, a 33.3% increase from 2022.
- Adma Biologics, Inc. annual Operating Lease, Payments for 2022 was $1.8M, a 28.6% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)